Clinical Trial Update: Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating saquinavir/ritonavir with tenofovir/emtricitabine in HIV patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• Saquinavir/ritonavir (saquinavir/ritonavir)
• Tenofovir/emtricitabine (tenofovir/emtricitabine)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID | Phase 2, Phase 3 | Status: WITHDRAWN